13 July 2020 - A patient advocate group says a pharmaceutical giant's decision to pull out of the New Zealand market has shocked Kiwi doctors, leaving patients are anxious about the risks of changing medications.
Apotex will pull its 41 medications from New Zealand at the end of 2021, the company announced last week, forcing PHARMAC to search for new suppliers.
The decision is expected to affect more than 1 million Kiwis who suffer from a range of injuries and illnesses, including hypertension, epilepsy and bipolar disorder.